Initial Therapeutics Revenue and Competitors

Location

$75M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Initial Therapeutics's estimated annual revenue is currently $2.2M per year.(i)
  • Initial Therapeutics's estimated revenue per employee is $77,500
  • Initial Therapeutics's total funding is $75M.

Employee Data

  • Initial Therapeutics has 28 Employees.(i)
  • Initial Therapeutics grew their employee count by 0% last year.

Initial Therapeutics's People

NameTitleEmail/Phone
1
President and CEOReveal Email/Phone
2
President and CEOReveal Email/Phone
3
Chief Scientific OfficerReveal Email/Phone
4
SVP, BiologyReveal Email/Phone
5
Sr. VP ChemistryReveal Email/Phone
6
Director, Platform BiologyReveal Email/Phone
7
Executive Director: Translational, Nonclinical & Clinical PharmacologyReveal Email/Phone
8
Manager, in vivo pharmacologyReveal Email/Phone
9
Associate ScientistReveal Email/Phone
10
Member, Scientific Advisory BoardReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M70-8%$53MN/A
#2
$32.4M167-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$0.8M5-50%N/AN/A
#6
$0.8M100%N/AN/A
#7
$14M90-12%N/AN/A
#8
$0.4M33610%$236.7MN/A
#9
$4.8M62-74%$160MN/A
#10
$3.7M24-8%N/AN/A
Add Company

What Is Initial Therapeutics?

Initial Therapeutics is discovering and developing a new class of small-molecule medicines designed to halt pathogenic protein formation in the earliest stages.Initial’s approach is unique and starkly differentiated from protein degradation and other interventions that recognize and tackle proteins only after they have been fully formed.

keywords:N/A

$75M

Total Funding

28

Number of Employees

$2.2M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.2M28-35%$9M
#2
$4.2M280%$51.2M
#3
$3.4M28-3%$24.9M
#4
$2.8M28N/AN/A
#5
$4.2M28-18%$11.4M